Transamerica Final Expense Insurance Fit Review for People With Diabetes

Research Snapshot

Why Transamerica Qualified for This Study

Questions This Section Answers

• Is Transamerica a good choice for Final Expense Insurance for People With Diabetes?
• Why did AI platforms rank Transamerica so highly for a diabetic senior seeking $15,000–$25,000 of coverage?

Transamerica qualified because it was named by six of the seven platforms during ranking discovery and placed near the top of nearly every list. Its average listed rank was 2.17, with openai ranking it first, deepseek, kimi, and perplexity ranking it second, and anthropic and grok ranking it third. Only google did not name it in the ranking stage.

The platforms converged on a specific reason: Transamerica's simplified-issue final expense products are structurally matched to the buyer's target. Immediate Solution and 10-Pay Solution are permanent whole-life designs with a $1,000 minimum and age-banded maximums of $50,000 through age 55, $40,000 at ages 56–65, $30,000 at ages 66–75, and $25,000 at ages 76–85, which accommodates the requested $15,000–$25,000 range ^[1]. Independent reviewers describe Express Select as a simplified-issue whole life policy with no medical exam, no blood work, and no doctor visit ^[2].

The second qualification driver was underwriting appetite. One independent review states that clients with insulin-dependent diabetes, diabetes combined with COPD, or heart disease with stents can often qualify for day-one coverage through Transamerica when Mutual of Omaha would decline or grade them ^[3]. Another describes Transamerica as the most forgiving carrier on diabetes complications among those reviewed ^[4]. This is the pattern that pushed Transamerica into the finalist set despite higher reported premiums.

The Product, Model, Plan, or Service Most Relevant to Final Expense Insurance for People With Diabetes

Questions This Section Answers

• Which Transamerica plan should a buyer with insulin-dependent diabetes choose for $15,000–$25,000 of day-one final expense coverage?
• Is Transamerica Express Select the same product as FE Express Solution or Immediate Solution?

The most relevant product is Transamerica's simplified-issue final expense whole life line, but the platforms did not agree on a single product name. This is a material conflict that buyers must resolve before applying.

The names that appear across platform responses include Express Select, FE Express Solution, Immediate Solution, 10-Pay Solution, Easy Solution, and Express Protect underwriting. Openai's research found that the ranking-stage labels "Express Select," "Select tier," and "Transamerica Express Select Whole Life" were not clearly identified in the current public final-expense documents it reviewed; those documents instead identify Immediate Solution, 10-Pay Solution, Easy Solution, and Express Protect underwriting ^[5]. Anthropic's research treats Express Select and FE Express Solution as related names for the same simplified-issue line, noting that FE Express appears to be a newer rebrand ^[7].

Functionally, the products described share these traits:

• Permanent whole-life coverage rather than term ^[5].
• Simplified-issue underwriting with health questions and prescription-history review, no medical exam ^[9].
• Day-one full death benefit for applicants who qualify for the top tiers, subject to a two-year contestability period ^[5].
• Level premiums: Immediate Solution to age 121, 10-Pay Solution for 10 years, Easy Solution to age 121 with graded benefits ^[6].

For a diabetic senior targeting $15,000–$25,000, the practical choice is between a day-one product (Immediate Solution, 10-Pay Solution, or the Express Select/FE Express tier that qualifies for full benefits) and the graded Easy Solution fallback. Easy Solution limits non-accidental death benefits in the first two years to roughly 110% of premiums paid, less any loan balance, with full face-amount coverage after that period ^[5].

What the AI Platforms Agreed About

Questions This Section Answers

• Do AI platforms agree that Transamerica is a good fit for a diabetic senior who needs day-one final expense coverage?
• What do the platforms agree Transamerica does better than other final expense carriers for applicants with diabetes?

Agreement was strong, though not unanimous, on four points.

1. Product structure fits the target. Every platform that named Transamerica described a permanent whole-life final expense product with simplified underwriting and coverage limits that reach the buyer's $15,000–$25,000 target. Openai documented the age-banded maximums directly from company materials ^[12]. Perplexity cited published maximums of $25,000 for ages 76–85 and $30,000 for ages 66–75 ^[13].

2. Diabetes underwriting is comparatively lenient. This was the most consistent theme. Anthropic reported that insulin-dependent diabetes without complications qualifies for Preferred or Standard rates with day-one full benefits, and that diabetes combined with COPD or heart disease can still reach Level coverage ^[15]. Grok reported leniency on insulin-dependent diabetes without recent hospitalization or amputation, and acceptance of complications such as neuropathy and retinopathy at Select/Level day-one ^[17]. Kimi described Transamerica as having the widest simplified-issue appetite among five core carriers for diabetic profiles, including many insulin users ^[20]. Google cited an underwriting guide stating onset before age 20 is a decline, onset after age 20 with insulin is standard, and oral medication is preferred ^[22].

3. No medical exam is required. Anthropic, deepseek, grok, kimi, and perplexity all described simplified-issue underwriting using health questions and prescription review rather than exams or labs ^[23].

4. Premiums are level for life. Anthropic and kimi both reported that premiums are guaranteed level and locked for the life of the policy ^[28].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Why do AI platforms disagree about Transamerica's pricing and product names for diabetic final expense applicants?
• What can't be verified about Transamerica's diabetes underwriting before a buyer applies?

Disagreement and uncertainty clustered in five areas.

Product naming. As noted above, openai could not locate "Express Select" in the current public final-expense documents it reviewed, while anthropic, deepseek, grok, kimi, and perplexity all used that name ^[31]. Perplexity explicitly flagged that public sources conflict on product naming and maximum face amounts across variants ^[37].

Pricing. Reported sample premiums vary by source and assumption. Anthropic and grok both cited approximately $61 per month for a 65-year-old female non-smoker at Select class for $10,000 of coverage ^[39]. Perplexity cited roughly $53 per month for a 70-year-old female and $70 for a 70-year-old male at $10,000, plus about $77.52 per month for a 70-year-old female at $15,000 ^[41]. Kimi published a full age-banded baseline table for Express Select, from $33/$39 per month at age 50 female/male to $134/$172 at age 80, per $10,000 of face amount ^[43]. These figures are not directly comparable because they use different ages, sexes, and coverage amounts.

Cost competitiveness. Anthropic reported that Express Select at $61 per month is higher than Mutual of Omaha at $41 per month for an equivalent 65-year-old female non-smoker at $10,000, but noted Transamerica accepts health conditions Mutual of Omaha declines ^[39]. Grok reported premiums 20–30% higher than Mutual of Omaha for comparable profiles ^[45]. Kimi reported that Transamerica rates run higher than Mutual of Omaha's Living Promise Level and Aflac's Final Expense Whole Life for a non-diabetic baseline ^[35]. Openai found no reliable public premium schedule for a senior with diabetes and $15,000–$25,000 of coverage and rated pricing confidence low ^[46].

Diabetes-specific underwriting thresholds. No platform found published A1C thresholds, insulin-use rules, or complication-specific acceptance criteria in consumer-facing materials. Deepseek stated that Transamerica generally does not publish a public per-condition diabetes underwriting grid, so eligibility must be determined at application ^[47]. Kimi flagged that exact A1C thresholds and medication guidelines are not publicly detailed ^[35]. Openai stated that the reviewed public materials do not state diabetes-specific acceptance rules, preferred diabetes profiles, guaranteed approval, or rate classes for type 1 or type 2 diabetes ^[31].

Customer service record. Anthropic reported a NAIC complaint index of 3.86, nearly four times the industry average of 1.0, a J.D. Power score of 604 placing Transamerica 18th of 21 carriers, and a Better Business Bureau rating of 1.66 out of 5 stars ^[48]. A separate source ranked Transamerica 22nd of 23 companies on J.D. Power customer satisfaction ^[51]. No other platform raised service quality as a factor, so this is a single-platform finding rather than a consensus view.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What coverage amounts and issue ages does Transamerica offer for a diabetic senior who wants $15,000–$25,000 of final expense insurance?
• Does Transamerica pay the full death benefit from day one for applicants with insulin-dependent diabetes?

The features most relevant to a diabetic senior are coverage range, day-one benefit structure, underwriting method, and premium guarantee.

Coverage range. Openai documented maximums of $50,000 through age 55, $40,000 at ages 56–65, $30,000 at ages 66–75, and $25,000 at ages 76–85 for Immediate Solution and 10-Pay Solution ^[52]. Anthropic cited FE Express maximums of $100,000 for ages 18–75 and $25,000 for ages 76–85, with a graded maximum of $25,000 at all issue ages ^[53]. Anthropic also reported Express Select face amounts of $2,000–$100,000 for applicants under age 76 ^[54]. These figures conflict, and the discrepancy likely reflects different product variants or different source vintages.

Day-one benefit. Openai stated that Immediate Solution and 10-Pay Solution provide the full death benefit from day one, subject to policy terms and the two-year contestability period ^[52]. Anthropic reported that applicants qualifying for Premier or Select receive full death benefit coverage from day one with no waiting period and no graded benefit schedule ^[56]. Anthropic also reported that a Graded class carries a two-year waiting period during which non-accidental death pays a return of premiums plus interest, with the full death benefit applying after two years ^[58].

Underwriting method. Simplified issue with health questions and prescription-history review; no exam, blood work, or doctor visit ^[61]. Anthropic reported approximately eight health questions by phone with same-day decisions possible ^[62]. One independent review reported all-digital underwriting with decisions in as little as 10 minutes ^[63], and another reported most applicants receive a decision within 15 minutes or less ^[64]. Openai noted that not all applicants qualify for nonmedical underwriting and that additional medical exams or data may be requested ^[65].

Premium guarantee. Premiums are guaranteed level and payable for the lifetime of the policy ^[66].

Cash value and riders. The products build tax-deferred cash value that may be borrowed against, with outstanding loans reducing the death benefit ^[52]. An Accelerated Death Benefit rider provides up to 75% of the current death benefit to a maximum of $250,000 per life, with a minimum payment of $10,000 ^[69]. Rider availability varies by jurisdiction ^[65].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Transamerica Express Select cost per month for a 65-year-old with diabetes, and is that cheaper than Mutual of Omaha?
• What fees, policy charges, and cancellation terms apply to a Transamerica final expense policy?

Pricing confidence across the platforms was low to moderate, and no platform verified a diabetes-specific rate. The figures below are sample quotes for non-diabetic or unspecified-health applicants and should be treated as reference points only.

Kimi reported that diabetic applicants typically pay 10–30% above non-diabetic rates for the same coverage, depending on tier and control, with graded-benefit rates running 30–50% above Level and guaranteed-issue rates running 40–80% above ^[70]. These multipliers are platform-reported and not verified against a carrier rate table.

Fees. Openai found no separate application fee in the reviewed public materials, but noted that optional riders may carry additional cost and that policy loans accrue interest at a variable rate not exceeding 8% ^[72]. Anthropic reported a possible $15 annual policy fee on some legacy products and flagged that recent sources do not confirm whether it applies to current products ^[73]. Google reported annual policy fees ranging from $15 to $42 depending on state and product version, plus modal factor fees if premiums are paid semi-annually, quarterly, or monthly rather than annually ^[74]. These fee figures conflict and require confirmation.

Contract terms. Policies remain in force only while required premiums are paid, subject to policy provisions, and are subject to a two-year contestability period ^[72]. Reduced paid-up and other nonforfeiture options may be available ^[72]. Exact free-look, lapse, surrender-charge, reinstatement, and state-specific cancellation terms were not verified from the reviewed materials ^[72].

Issuer and jurisdiction. Policies are issued by Transamerica life insurance Company outside New York and Transamerica Financial Life Insurance Company in New York; policy forms, riders, and product availability vary by jurisdiction ^[78]. The electronic application is not available in New York according to the reviewed portfolio material ^[79]. Grok reported availability limited in some states including California, New York, and Pennsylvania per agent guides ^[80].

Best Suited For

Questions This Section Answers

• Who is Transamerica best suited for among seniors with diabetes seeking final expense coverage?
• Is Transamerica a good fit for a diabetic applicant who was already declined or graded by Mutual of Omaha?

Transamerica is best suited for a diabetic senior who values approval odds over the lowest possible price. The platforms most consistently identified these buyer profiles:

• Seniors with insulin-dependent diabetes without significant complications who want day-one full benefits ^[81].
• Applicants previously declined or graded by Mutual of Omaha or other stricter carriers because of diabetes or multi-condition profiles ^[83].
• Buyers with diabetes combined with COPD, heart disease, or other paired conditions that stricter carriers decline or grade ^[86].
• Applicants who want $15,000–$25,000 of permanent coverage without a medical exam ^[88].
• Buyers who prefer level premiums to age 121 or a 10-year premium-payment period ^[90].
• Applicants who want a fast underwriting decision rather than a four-to-seven-week fully underwritten process ^[91].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Transamerica for Final Expense Insurance for People With Diabetes?
• Is Transamerica a bad choice for a diabetic applicant who needs guaranteed acceptance with no health questions?

Transamerica is probably not the best choice for these buyers:

• Applicants who need guaranteed acceptance regardless of diabetes complications or other health conditions. Simplified issue is not guaranteed issue; diabetes or related complications may lead to declination, higher premiums, modified terms, or additional requirements ^[93].
• Applicants whose priority is the lowest possible premium and who can qualify for fully underwritten coverage elsewhere ^[94].
• Applicants with juvenile-onset diabetes. Google cited an underwriting guide stating onset before age 20 is a decline, excluding gestational diabetes ^[96].
• Applicants with a history of diabetic coma. Google cited a company application question listing diabetic coma as a knockout ^[97].
• Applicants with recent diabetes-related hospitalization or amputation within 12 months, who typically face guaranteed-issue constraints at any carrier ^[98].
• Applicants who need coverage above the age-based maximums, which drop to $25,000 at ages 76–85 ^[99].
• Buyers who prioritize top-tier customer service ratings. Anthropic reported a NAIC complaint index of 3.86 against an industry average of 1.0 and a J.D. Power rank of 18 of 21 carriers ^[101].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Transamerica for a diabetic buyer who needs guaranteed issue with no health questions?
• When should a diabetic senior choose a different carrier instead of Transamerica for final expense insurance?

Another option may be better in these situations:

• Guaranteed issue is required. When diabetes complications make simplified underwriting uncertain and the buyer accepts graded benefits and potentially higher cost, a guaranteed-issue final expense carrier is preferable ^[103]. Kimi noted that recent hospitalization, amputation, or uncontrolled diabetes results in guaranteed issue with a two-year wait at any carrier, not a Transamerica-specific limitation ^[104].
• Lowest premium is the priority. Mutual of Omaha Living Promise was cited at approximately $41 per month versus Transamerica Express Select at approximately $61 per month for a 65-year-old female non-smoker at $10,000 ^[105].
• Published diabetes underwriting guidelines are required before applying. A carrier with explicit, public diabetes underwriting criteria may be preferable when the buyer's main objective is favorable treatment of a specific diabetes profile ^[103].
• Fully underwritten coverage is viable. A fully underwritten traditional whole-life carrier may be better when the applicant is medically favorable and wants to compare lower premiums or higher coverage ^[103].
• State availability or age limits do not fit. Another carrier may be better when Transamerica's state availability, age limits, or $25,000 maximum does not meet the buyer's needs ^[103].
• Significant cash value growth is the goal. Participating whole life from mutual carriers may offer dividend growth, while Transamerica's non-participating policy has limited cash value upside ^[105].

Questions to Verify Before Buying

The platforms supplied overlapping verification lists. Consolidated, the questions a buyer should confirm with Transamerica or an agent before signing are:

1. For the applicant's exact age, state, diabetes type, A1C and control history, medications, complications, and tobacco status, will Transamerica offer Immediate Solution, 10-Pay Solution, Express Select, or only a graded product ^[109]?
2. What underwriting class is offered — Preferred, Select, Standard, Graded, or another tier — and what are the corresponding day-one versus waiting-period terms ^[110]?
3. Will an exam, labs, prescription report, or physician records be required ^[109]?
4. What is the exact monthly or annual premium for $15,000, $20,000, and $25,000, and is it guaranteed for the stated payment period ^[109]?
5. Does coverage begin with the full death benefit on day one for this applicant and state, and how does the two-year contestability provision apply ^[112]?
6. Is 10-Pay Solution available in the applicant's state and at the applicant's age ^[109]?
7. What is the current policy fee, if any, and will it remain level for life ^[110]?
8. Which riders are available, what do they cost, and what exclusions, qualification rules, and tax consequences apply ^[112]?
9. What are the free-look period, lapse grace period, surrender values, loan interest terms, reinstatement rules, and reduced-paid-up options ^[112]?
10. Which legal issuer will issue the policy in the applicant's state, and what policy form and state-specific limitations apply ^[109]?
11. If declined or placed in a graded plan, which alternative Transamerica product or other carrier would provide the best available day-one coverage ^[109]?
12. How do Transamerica's quotes compare with two or three competing final expense carriers for the same health profile ^[115]?

Final AI Consensus Verdict

Transamerica is a good fit for a senior with well-managed or otherwise insurable diabetes seeking approximately $15,000–$25,000 of permanent final expense coverage, with meaningful uncertainty that buyers must resolve before applying. Five platforms rated the fit "good" and two rated it "strong." The consensus case rests on three verified structural facts: the products are permanent whole life with coverage limits that reach the target range, underwriting is simplified with no medical exam, and day-one full benefits are available for applicants who qualify for the top tiers. The consensus case also rests on a widely reported but not publicly documented claim: that Transamerica's diabetes underwriting is more lenient than competitors', including for insulin users and some paired conditions.

The decisive issue is applicant-specific underwriting, which no public source verifies. Transamerica does not publish diabetes-specific acceptance rules, A1C thresholds, or rate classes. Buyers should treat the reported leniency as a reason to get a quote, not as a reason to assume approval. Reported premiums are higher than Mutual of Omaha for equivalent applicants, and one platform reported elevated complaint and satisfaction concerns. The practical path is to obtain a written underwriting classification and premium illustration for the exact diabetes profile, then compare against at least two competing carriers before committing.

How This Review Was Produced

This review synthesizes fit-research responses from seven AI platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — each of which independently evaluated Transamerica against the use case of a senior with diabetes seeking $15,000–$25,000 of permanent final expense coverage. Six of the seven named Transamerica during the ranking stage. Each platform supplied its own citations, fit rating, strengths, limitations, pricing notes, and verification questions. Those inputs were consolidated, deduplicated, and checked for conflicts. Where platforms disagreed, the conflict is disclosed rather than resolved. The consensus index for this category is available at Final Expense Insurance for People With Diabetes, and broader carrier comparisons sit in the life insurance directory.

Methodology Limitations

• The authoritative run research date is 2026-09-22. Platform-reported research dates differ: deepseek reported 2026-01-15, while the other six platforms reported 2026-09-23. Platform-reported dates are provenance metadata and do not independently prove freshness.
• All included platforms evaluated fit, but the platform mention count reflects only platforms that named Transamerica during ranking discovery. Google evaluated fit but did not name Transamerica in the ranking stage.
• Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage.
• Deepseek's research ran with search disabled, so its claims are model-reported rather than retrieved from live sources.
• Product naming conflicts were not resolved. "Express Select," "FE Express Solution," "Immediate Solution," "10-Pay Solution," and "Easy Solution" appear across platform responses with inconsistent mapping to current public documents.
• Some Transamerica marketing materials cited are dated 2020–2023, so current 2026 availability, policy forms, underwriting rules, and limits require confirmation.
• No public diabetes-specific premium examples or underwriting thresholds were verified by any platform.
• Customer service findings (NAIC complaint index, J.D. Power ranking, BBB rating) came from a single platform and were not corroborated by others.
• AI-platform agreement does not prove product quality, underwriting outcomes, or claims performance.